Effects of a dietary supplement (SV) on advanced non small cell lung cancer patients treated with best supportive care (BSC): A randomized double-blind placebo controlled study, a phase III Trial

ID Number 01-0150-00003

Principal Investigator(s)
Henry Sacks

Department(s) or Division(s)
Preventive Medicine


The purpose of this study is to evaluate the effects of a dietary supplement called “Selected Vegetable Herb Mix (SV)” in advanced Non-Small Cell Lung Cancer (NSCLC) patients receiving standard chemotherapy.

You may qualify because you have been diagnosed with non-small-cell-carcinoma of the lung and are or will be receiving standard treatment for your disease. Standard treatment is chemotherapy, (a combination of medications that may reduce tumor size) that is prescribed by your oncologist, (the doctor treating your cancer).

Contact Information
Maud Dupuy
(212) 241-8254

Recruiting Patients: Yes